CA2611072A1 - Composes inedits et leurs utilisations - Google Patents
Composes inedits et leurs utilisations Download PDFInfo
- Publication number
- CA2611072A1 CA2611072A1 CA002611072A CA2611072A CA2611072A1 CA 2611072 A1 CA2611072 A1 CA 2611072A1 CA 002611072 A CA002611072 A CA 002611072A CA 2611072 A CA2611072 A CA 2611072A CA 2611072 A1 CA2611072 A1 CA 2611072A1
- Authority
- CA
- Canada
- Prior art keywords
- optionally substituted
- compound
- 6alkyl
- irap
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002611072A CA2611072A1 (fr) | 2007-11-19 | 2007-11-19 | Composes inedits et leurs utilisations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002611072A CA2611072A1 (fr) | 2007-11-19 | 2007-11-19 | Composes inedits et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2611072A1 true CA2611072A1 (fr) | 2009-05-19 |
Family
ID=40652816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002611072A Abandoned CA2611072A1 (fr) | 2007-11-19 | 2007-11-19 | Composes inedits et leurs utilisations |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2611072A1 (fr) |
-
2007
- 2007-11-19 CA CA002611072A patent/CA2611072A1/fr not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8377963B2 (en) | Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof | |
Chowdhury et al. | Phenotypic optimization of urea–thiophene carboxamides to yield potent, well tolerated, and orally active protective agents against aminoglycoside-induced hearing loss | |
Chen et al. | 5-Cyano-6-oxo-1, 6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP | |
US8008341B2 (en) | Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases | |
ES2403340T3 (es) | Inhibidores de aminopeptidasa regulada por insulina (IRAP) y usos de los mismos | |
TWI653226B (zh) | 雜環衍生物及其用途 | |
JP2000510164A (ja) | 選択的神経ペプチドy受容体アンタゴニストとしてのアミド誘導体 | |
CN102850324A (zh) | 吲哚化合物 | |
US20210340547A1 (en) | Fibrotic treatment | |
ES2782357T3 (es) | Inhibidores de IRE 1 alfa | |
ES2388196T3 (es) | Derivados de 2-aril- y 2-heteroaril-4H-1-benzopiran-4-ona-6-amidino para el tratamiento de artritis, cáncer y dolor relacionado | |
CN103189357B (zh) | 作为kcnq2/3调节剂的取代的2-氧代-和2-硫代-二氢喹啉-3-甲酰胺 | |
EP3294721A1 (fr) | Composés 4h-pyrane utilisés comme inhibiteurs de l'aminopeptidase régulée par l'insuline (irap) | |
CA2611072A1 (fr) | Composes inedits et leurs utilisations | |
AU2007234577A1 (en) | Novel compounds and uses thereof | |
US9828351B2 (en) | Enzyme interacting agents | |
Li et al. | Discovery of phenanthridine analogues as novel chemical probes disrupting the binding of DNA to ΔFosB homodimers and ΔFosB/JunD heterodimers | |
EP3801511A1 (fr) | Dérivés de thiéno[2,3-b] pyridine en tant qu'inhibiteurs d'epac et leurs utilisations pharmaceutiques | |
AU2005282229B2 (en) | Enzyme inhibitors and uses thereof | |
CN1148353C (zh) | 一类磷脂酶甲2的抑制剂及其制备方法和用途 | |
CN101679254A (zh) | 用于炎症治疗的哌啶酮类 | |
Asquith et al. | Design and evaluation of novel 4-anilinoquinolines and quinazolines EGFR inhibitors in lung cancer and chordoma | |
CA2704250A1 (fr) | Composes d'aryloxyamine et leur utilisation comme modulateurs des canaux sodiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |
Effective date: 20141119 |